logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

C. Steendam

Erasmus University Rotterdam
H指数:9
被引数:173

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective clinical evaluation of cell-free DNA next generation sequencing in patients with suspected metastatic lung cancer

疑似转移性肺癌患者中游离DNA下一代测序的前瞻性临床评估

Scientific Reports
IF3.9
2026-04-080
OAAI
Christi M. J. Steendam; Ruud W. J. Meijers; Peggy Atmodimedjo; Lisette van Dijk; Cor van der Leest; Keetie C. J. van Loenhout; Susan C. van ’t Westeinde; Daphne W. Dumoulin; Wessel E. J. J. Hanselaar; Marthe S. Paats; Evert de Jonge; Ron H. N. van Schaik; Jan H. von der Thüsen; Joachim G. J. V. Aerts; Anne-Marie C. Dingemans; Hendrikus Jan Dubbink
Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastases

非小细胞肺癌患者在接受一线（化疗-）免疫治疗期间发生脑转移的临床危险因素（基线时无已知脑转移）

Lung Cancer
IF4.4
2025-09-020
OAAI
Jarno W.J. Huijs; Anna M. Sadowska; Juliette H.R.J. Degens; Christi M.J. Steendam; Frederike Bensch; Lucie B.M. Hijmering-Kappelle; Tom M.T. de Schrevel; Wouter H. van Geffen; Magdolen Youssef-El Soud; Michelle M.H. Steens; Cordula Pitz; Dirk K.M. De Ruysscher; Lizza E.L. Hendriks
Connecting the dots: (RANKL plus ) extracellular vesicle count in blood plasma in relation to bone metastases, skeletal related events and osimertinib treatment in patients with EGFR mutated non-small cell lung cancer

连接数据点：(RANKL plus) 血浆外泌体计数与骨转移、骨骼相关事件以及奥希替尼治疗在EGFR突变非小细胞肺癌患者中的关系

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2025-03-010
OA
Brouns, Anita J. W. M.; Robbesom-van den Berge, Iris J.; Ernst, Sophie M.; Steendam, Christi M. J.; Woud, Wouter W.; Wu, Liang; Dingemans, Anne-Marie C.; Hendriks, Lizza E. L.; van Driel, Marjolein
Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

奥希替尼血浆谷浓度与晚期EGFR突变NSCLC患者脑转移发生的关系

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-04-011
OA
Gulikers, Judith L.; Veerman, G. D. Marijn; Jebbink, Merel; Kruithof, Paul D.; Steendam, Christi M. J.; Boosman, Rene J.; Mathijssen, Ron H. J.; Tjan-Heijnen, Vivianne C. G.; Driessen, Johanna H. M.; Dursun, Safiye; Smit, Egbert F.; Dingemans, Anne -Marie C.; van Geel, Robin M. J. M.; Croes, Sander; Hendriks, Lizza E. L.
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2023-10-156
OA
van Veelen, Ard; Veerman, G. D. Marijn; Verschueren, Marjon V.; Gulikers, Judith L.; Steendam, Christi M. J.; Brouns, Anita J. W. M.; Dursun, Safiye; Paats, Marthe S.; Tjan-Heijnen, Vivianne C. G.; van der Leest, Cor; Dingemans, Anne-Marie C.; Mathijssen, Ron H. J.; van de Garde, Ewoudt M. W.; Souverein, Patrick; Driessen, Johanna H. M.; Hendriks, Lizza E. L.; van Geel, Robin M. J. M.; Croes, Sander
Peripheral osimertinib (osi) plasma trough concentration (Cmin,SS) as surrogate parameter for development and progression of brain metastasis (BM) in patients (pts) with EGFR plus advanced non-small cell lung cancer (aNSCLC)
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OAAI
Gulikers, J. L.; Veerman, M. G. D.; Jebbink, M.; Kruithof, P.; Steendam, C. M. J.; Boosman, R.; Mathijssen, R. H.; Tjan-Heijnen, V.; Driessen, A.; Dursun, S.; Smit, E. F.; Dingemans, A-M. C.; van Geel, R.; Croes, S.; Hendriks, L.

研究方向

暂未获取到该数据
A
Anne‐Marie C. Dingemans
H 指数:71论文数:674被引数:2.0万
R
Ron H.J. Mathijssen
H 指数:76论文数:888被引数:2.0万
L
Lizza Hendriks
H 指数:48论文数:432被引数:1.0万
G
G. Veerman
H 指数:22论文数:71被引数:2,348
E
Egbert F. Smit
H 指数:113论文数:1,213被引数:6.0万
S
Sander Croes
H 指数:17论文数:68被引数:942
S
Safiye Dursun
H 指数:8论文数:21被引数:115
S
Stijn L.W. Koolen
H 指数:30论文数:257被引数:3,548
A
A. Brouns
H 指数:6论文数:26被引数:79
C
Cor van der Leest
H 指数:13论文数:53被引数:1,497